PolyPid
PYPD
19 hedge funds and large institutions have $11.9M invested in PolyPid in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0.02% less ownership
Funds ownership: 0.29% → 0.27% (-0.02%)
12% less capital invested
Capital invested by funds: $13.5M → $11.9M (-$1.57M)
14% less funds holding
Funds holding: 22 → 19 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$410K |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$233K |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$138K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$36.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.09M |
| 2 |
Millennium Management
New York
|
-$512K |
| 3 |
Renaissance Technologies
New York
|
-$174K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$24.6K |
| 5 |
MCM
Moore Capital Management
New York
|
-$16.6K |
PYPD Hedge Fund Activity: Q3 2021 in Review
19 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q3 2021, worth a combined $11.9M — down 12% from $13.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PYPD and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was UBS Group, adding an estimated $410K. The largest seller was ARK Investment Management, cutting an estimated $1.09M.
- 19 institutional investors held PolyPid (PYPD) as of Q3 2021, down from 22 in Q2 2021.
- Funds reported $11.9M of PolyPid stock for Q3 2021, down 12% quarter-over-quarter.
- 0 funds opened new PolyPid positions in Q3 2021 and 3 closed out, a net change of -3 holders.
- The largest PolyPid buyer in Q3 2021 was UBS Group, an estimated $410K added.
- The largest PolyPid seller in Q3 2021 was ARK Investment Management, an estimated $1.09M sold.
Based on aggregated 13F filings for Q3 2021.